Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2011-08-30
2011-08-30
Chong, Kimberly (Department: 1635)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C536S024310, C536S024100, C514S04400A
Reexamination Certificate
active
08008468
ABSTRACT:
The present invention provides compositions and methods suitable for RNAi specifically in the liver so as to treat diseases or disorders.
REFERENCES:
patent: 6218181 (2001-04-01), Verma et al.
patent: 6509323 (2003-01-01), Davis et al.
patent: 6573099 (2003-06-01), Graham
patent: 6808905 (2004-10-01), McArthur et al.
patent: 2004/0214329 (2004-10-01), Kay et al.
patent: 2004/0220130 (2004-11-01), Robbins et al.
patent: 2005/0008617 (2005-01-01), Chen et al.
Anderson et al. Bispecific Short Hairpin siRNA constructs targeted to CD4, CXCR$ and CCR5 Confer HIV-1 Resistance. Oligonucleotides 2003, vol. 13, pp. 303-312.
Wu et al. Inhibition of hepatitis viral replication by siRNA. Expert Opinion Biol. Ther. 2004, vol. 4(10), pp. 1649-1659.
Wilson et al. RNA interference blocks gene expression and RNA synthesis from hepatitis C replicons propagated in human liver cells. PNAS 2003, vol. 100m No. 5, pp. 2783-2788.
Maniatis et al.,Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Press, Cold Spring Harbor, NY (1982).
Sambrook et al.,Molecular Cloning: A Laboratory Manual, 2nd Ed., Cold Spring Harbor Press, Cold Spring Harbor, NY (1989).
D.N. Glover,DNA Cloning: A Practical Approach, vols. I and II, Oxford University Press (1985).
M.J. Gait,Oligonucleotide Synthesis: A Practical Approach, Oxford University Press (1984).
B.D. Hames et al,Nucleic Acid Hybridization: A Practical Approach, Oxford University Press (1984).
R.I. FreshneyAnimal Cell Culture, IRL Press (1986).
J.A. Cann et al.,RNA Viruses: A Practical Approach, Oxford University Press (2000).
McOmie,Protective Groups in Organic Chemistry, ed., Plenum Press, NY, NY (1973).
Greene, ProtectiveGroups in Organic Synthesis, ed., John Wiley & Sons, NY (1981).
Karlin, S. et al., “Applications and Statistics for Multiple High-Scoring Segments in Molecular Sequences”,Proc. Natl. Acad. Sci., 1993, vol. 90, No. 12, pp. 5873-5877.
Pearson et al., “Improved Tools for Biological Sequence Comparison,”Proceedings of the National Academy of Science of the United States of America, 1988, vol. 85, pp. 2444-2448.
Myers et al., Optimal Alignments in Linear Space,CABIOS, 1988, vol. 4, No. 1, pp. 11-17.
Fire et al., “Potent and Specific Genetic Interference by Double-Stranded RNA inCaenorhabditis elegans,” Nature, 1998, vol. 391, pp. 806-811.
Tuschl et al., “Targeted mRNA Degradation by Double-Stranded RNA in Vitro”Genes&Development, 1999, vol. 13, pp. 3191-3197.
Elbashir et al., “Duplexes of 21-Nucleotide RNAs Mediate RNA Interference in Cultured Mammalian Cells,”Nature, 2001, vol. 411, pp. 494-498.
Kurreck, J., “Antisense Technologies: Improvement Through Novel Chemical Modifications,”Eur. J. Biochem, 2003, vol. 270, pp. 1628-1644.
Harborth et al., “Sequence, Chemical, and Structural Variation of Small Interfering RNAs and Short Hairpin RNAs and the Effect of Mammalian Gene Silencing,”Antisense and Nucleic Acid Drug Development, 2003, vol. 13, pp. 83-105.
Ashfield et al., “MAZ-Dependent Termination Between Closely Spaced Human Complement Genes,”The EMBO Journal, 1994, vol. 13, No. 23, pp. 5656-5667.
Yonaha et al., “Transcriptional Termination and Coupled Polyadenylation in Vitro,”The EMBO Journal, 2000, vol. 19, No. 14, pp. 3770-3777.
Gitlin et al., “Poliovirus Escape from RNA Interference: Short Interfering RNA-Target Recognition and Implications for Therapeutic Approaches,”Journal of Virology, 2005, vol. 79, No. 2, pp. 1027-1035.
Nakai et al., “A Limited Number of Transducible Hepatocytes Restricts a Wide-Range Linear Vector Dose Response in Recombinant Adeno-Associated Virus-Mediated Liver Transduction,”Journal of Virology, 2002, vol. 76, No. 22, pp. 11343-11349.
Kay et al., “Looking into the Safety of AAV Vectors,”Nature, vol. 424, p. 251, 2003.
Thomas et al., “Progress and Problems with the Use of Viral Vectors for Gene Therapy,”Nature Reviews, Genetics, 2003, vol. 4, pp. 346-358.
Tomar et al., “Use of Adeno-Associated Viral Vector for Delivery of Small Interfering RNA,”Oncogene, 2003, vol. 22, pp. 5712-5715.
Boden et al., “Human Immunodeficiency Virus Type 1 Escape from RNA Interference,”Journal of Virology, 2003, vol. 77, No. 21, 11531-11535.
Mingozzi et al., “Improved Hepatic Gene Transfer by Using an Adeno-Associated Virus Serotype 5 Vector,”Journal of Virology, 2002, vol. 76, No. 20, pp. 10497-10502.
Thomas et al., “Rapid Uncoating of Vector Genomes is the Key to Efficient Liver Transduction with Pseudotyped Adeno-Associated Virus Vectors,”Journal of Virology, 2004, vol. 78, No. 6, pp. 3110-3122.
Grimm et al., “Preclinical in Vivo Evaluation of Pseudotyped Adeno-Associated Virus Vectors for Liver Gene Therapy,”Blood, 2003, vol. 102, No. 7, pp. 2412-2419.
Wang et al., “Rapid and Highly Efficient Transduction by Double-Stranded Adeno-Associated Virus Vectors in Vitro and in Vivo,”Gene Therapy, 2003, vol. 10, pp. 2105-2111.
Nakai et al., “Unrestricted Hepatocyte Transduction with Adeno-Associated Virus Serotype 8 Vectors in Mice,”Journal of Virology, 2005, vol. 79, No. 1, pp. 214-224.
Grimm et al., “Liver Transduction with Recombinant Adeno-Associated Virus is Primarily Restricted by Capsid Serotype Not Vector Genotype,”Journal of Virology, 2006, vol. 80, No. 1, pp. 426-439.
Yant et al., “Transposition from a Gutless Adeno-Transposon Vector Stabilizes Transgene Expression in Vivo,”Nature: Biotechnology, 2002, vol. 20, pp. 999-1005.
Perri et al., “Replicon Vectors Derived from Sindbis Virus and Semliki Forest Virus that Establish Persistent Replication in Host Cells,”Journal of Virology, 2000, vol. 74, No. 20, pp. 9802-9807.
Chen et al., “Minicircle DNA Vectors Devoid of Bacterial DNA Result in Persistent and High-Level Transgene Expression in Vivo,”Molecular Therapy, 2003, vol. 8, No. 3, pp. 495-500.
Tang et al., “Genetic Immunization is a Simple Method for Eliciting an Immune Response,”Nature, 1992, vol. 356, pp. 152-154.
Yokota et al., “Inhibition of Intracellular Hepatitis C Virus Replication by Synthetic and Vector-Derived Small Interfering RNAs,”EMBO Reports, 2003, vol. 4, No. 6, pp. 602-608.
Miao et al., “Inclusion of the Hepatic Locus Control Region, an Intron, and Untranslated Region Increases and Stabilizes Hepatic Factor IX Gene Expression in Vivo but NOT in Vitro,”Molecular Therapy, 2000, vol. 1, No. 6, pp. 522-532.
Giering Jeffery C.
Kay Mark A.
Kolykhalov Alexander A.
Roelvink Petrus W.
Suhy David A.
Benitec, Inc.
Chong Kimberly
Patton & Boggs LLP
LandOfFree
RNAi expression constructs with liver-specific... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with RNAi expression constructs with liver-specific..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and RNAi expression constructs with liver-specific... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2742168